Yujiro Hayashi1, Yoshitaka Toyomasu1, Siva Arumugam Saravanaperumal1, Michael R Bardsley1, John A Smestad2, Andrea Lorincz1, Seth T Eisenman3, Gianluca Cipriani3, Molly H Nelson Holte2, Fatimah J Al Khazal2, Sabriya A Syed4, Gabriella B Gajdos1, Kyoung Moo Choi3, Gary J Stoltz5, Katie E Miller5, Michael L Kendrick6, Brian P Rubin7, Simon J Gibbons5, Adil E Bharucha8, David R Linden5, Louis James Maher2, Gianrico Farrugia3, Tamas Ordog9. 1. Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. 2. Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota. 3. Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota. 4. Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota. 5. Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota. 6. Department of Surgery, Mayo Clinic, Rochester, Minnesota. 7. Departments of Anatomic Pathology and Cancer Biology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Lerner Research Institute and Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio. 8. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. 9. Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: ordog.tamas@mayo.edu.
Abstract
BACKGROUND & AIMS: Depletion of interstitial cells of Cajal (ICCs) is common in diabetic gastroparesis. However, in approximately 20% of patients with diabetes, gastric emptying (GE) is accelerated. GE also occurs faster in obese individuals, and is associated with increased blood levels of glucose in patients with type 2 diabetes. To understand the fate of ICCs in hyperinsulinemic, hyperglycemic states characterized by rapid GE, we studied mice with mutation of the leptin receptor (Leprdb/db), which in our colony had accelerated GE. We also investigated hyperglycemia-induced signaling in the ICC lineage and ICC dependence on glucose oxidative metabolism in mice with disruption of the succinate dehydrogenase complex, subunit C gene (Sdhc). METHODS: Mice were given breath tests to analyze GE of solids. ICCs were studied by flow cytometry, intracellular electrophysiology, isometric contractility measurement, reverse-transcription polymerase chain reaction, immunoblot, immunohistochemistry, enzyme-linked immunosorbent assays, and metabolite assays; cells and tissues were manipulated pharmacologically and by RNA interference. Viable cell counts, proliferation, and apoptosis were determined by methyltetrazolium, Ki-67, proliferating cell nuclear antigen, bromodeoxyuridine, and caspase-Glo 3/7 assays. Sdhc was disrupted in 2 different strains of mice via cre recombinase. RESULTS: In obese, hyperglycemic, hyperinsulinemic female Leprdb/db mice, GE was accelerated and gastric ICC and phasic cholinergic responses were increased. Female KitK641E/+ mice, which have genetically induced hyperplasia of ICCs, also had accelerated GE. In isolated cells of the ICC lineage and gastric organotypic cultures, hyperglycemia stimulated proliferation by mitogen-activated protein kinase 1 (MAPK1)- and MAPK3-dependent stabilization of ets variant 1-a master transcription factor for ICCs-and consequent up-regulation of v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) receptor tyrosine kinase. Opposite changes occurred in mice with disruption of Sdhc. CONCLUSIONS: Hyperglycemia increases ICCs via oxidative metabolism-dependent, MAPK1- and MAPK3-mediated stabilization of ets variant 1 and increased expression of KIT, causing rapid GE. Increases in ICCs might contribute to the acceleration in GE observed in some patients with diabetes.
BACKGROUND & AIMS: Depletion of interstitial cells of Cajal (ICCs) is common in diabetic gastroparesis. However, in approximately 20% of patients with diabetes, gastric emptying (GE) is accelerated. GE also occurs faster in obese individuals, and is associated with increased blood levels of glucose in patients with type 2 diabetes. To understand the fate of ICCs in hyperinsulinemic, hyperglycemic states characterized by rapid GE, we studied mice with mutation of the leptin receptor (Leprdb/db), which in our colony had accelerated GE. We also investigated hyperglycemia-induced signaling in the ICC lineage and ICC dependence on glucose oxidative metabolism in mice with disruption of the succinate dehydrogenase complex, subunit C gene (Sdhc). METHODS:Mice were given breath tests to analyze GE of solids. ICCs were studied by flow cytometry, intracellular electrophysiology, isometric contractility measurement, reverse-transcription polymerase chain reaction, immunoblot, immunohistochemistry, enzyme-linked immunosorbent assays, and metabolite assays; cells and tissues were manipulated pharmacologically and by RNA interference. Viable cell counts, proliferation, and apoptosis were determined by methyltetrazolium, Ki-67, proliferating cell nuclear antigen, bromodeoxyuridine, and caspase-Glo 3/7 assays. Sdhc was disrupted in 2 different strains of mice via cre recombinase. RESULTS: In obese, hyperglycemic, hyperinsulinemic female Leprdb/db mice, GE was accelerated and gastric ICC and phasic cholinergic responses were increased. Female KitK641E/+ mice, which have genetically induced hyperplasia of ICCs, also had accelerated GE. In isolated cells of the ICC lineage and gastric organotypic cultures, hyperglycemia stimulated proliferation by mitogen-activated protein kinase 1 (MAPK1)- and MAPK3-dependent stabilization of ets variant 1-a master transcription factor for ICCs-and consequent up-regulation of v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) receptor tyrosine kinase. Opposite changes occurred in mice with disruption of Sdhc. CONCLUSIONS:Hyperglycemia increases ICCs via oxidative metabolism-dependent, MAPK1- and MAPK3-mediated stabilization of ets variant 1 and increased expression of KIT, causing rapid GE. Increases in ICCs might contribute to the acceleration in GE observed in some patients with diabetes.
Authors: Maneesh Dave; Yujiro Hayashi; Gabriella B Gajdos; Thomas C Smyrk; Phyllis A Svingen; Sergiy M Kvasha; Andrea Lorincz; Haidong Dong; William A Faubion; Tamas Ordog Journal: Gastroenterology Date: 2015-01-28 Impact factor: 22.682
Authors: Madhusudan Grover; Gianrico Farrugia; Matthew S Lurken; Cheryl E Bernard; Maria Simonetta Faussone-Pellegrini; Thomas C Smyrk; Henry P Parkman; Thomas L Abell; William J Snape; William L Hasler; Aynur Ünalp-Arida; Linda Nguyen; Kenneth L Koch; Jorges Calles; Linda Lee; James Tonascia; Frank A Hamilton; Pankaj J Pasricha Journal: Gastroenterology Date: 2011-02-04 Impact factor: 22.682
Authors: Arlene N James; James P Ryan; Michael D Crowell; Henry P Parkman Journal: Am J Physiol Gastrointest Liver Physiol Date: 2004-04-23 Impact factor: 4.052
Authors: Kyoung Moo Choi; Jin Zhu; Gary J Stoltz; Steven Vernino; Michael Camilleri; Joseph H Szurszewski; Simon J Gibbons; Gianrico Farrugia Journal: Am J Physiol Gastrointest Liver Physiol Date: 2007-09-20 Impact factor: 4.052
Authors: Pedro J Gomez-Pinilla; Simon J Gibbons; Michael R Bardsley; Andrea Lorincz; Maria J Pozo; Pankaj J Pasricha; Matt Van de Rijn; Robert B West; Michael G Sarr; Michael L Kendrick; Robert R Cima; Eric J Dozois; David W Larson; Tamas Ordog; Gianrico Farrugia Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-04-16 Impact factor: 4.052
Authors: Andrea Lorincz; Doug Redelman; Viktor J Horváth; Michael R Bardsley; Hui Chen; Tamás Ordög Journal: Gastroenterology Date: 2008-01-18 Impact factor: 22.682
Authors: Ping Chi; Yu Chen; Lei Zhang; Xingyi Guo; John Wongvipat; Tambudzai Shamu; Jonathan A Fletcher; Scott Dewell; Robert G Maki; Deyou Zheng; Cristina R Antonescu; C David Allis; Charles L Sawyers Journal: Nature Date: 2010-10-03 Impact factor: 49.962
Authors: Amy A Worth; Abigail S Forrest; Lauren E Peri; Sean M Ward; Grant W Hennig; Kenton M Sanders Journal: J Neurogastroenterol Motil Date: 2015-03-30 Impact factor: 4.924
Authors: Michael Camilleri; Victor Chedid; Alexander C Ford; Ken Haruma; Michael Horowitz; Karen L Jones; Phillip A Low; Seon-Young Park; Henry P Parkman; Vincenzo Stanghellini Journal: Nat Rev Dis Primers Date: 2018-11-01 Impact factor: 52.329
Authors: K E Miller; Ž Bajzer; S S Hein; J E Phillips; S Syed; A M Wright; G Cipriani; S J Gibbons; J H Szurszewski; G Farrugia; T Ordog; D R Linden Journal: Neurogastroenterol Motil Date: 2018-03-25 Impact factor: 3.598
Authors: Onur Cil; Marc O Anderson; Robert Yen; Bryan Kelleher; Tony L Huynh; Youngho Seo; Steven P Nilsen; Jerrold R Turner; Alan S Verkman Journal: FASEB J Date: 2019-07-12 Impact factor: 5.834
Authors: Gianluca Cipriani; Simon J Gibbons; Katie E Miller; Daniel S Yang; Matthew L Terhaar; Seth T Eisenman; Tamas Ördög; David R Linden; Gabriela B Gajdos; Joseph H Szurszewski; Gianrico Farrugia Journal: Gastroenterology Date: 2018-03-06 Impact factor: 33.883